Carl Vaccaro, DO
Hospitalist · Pomona, NJNPI 1528245461
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,322 and has fallen 98.6% since, to $19 in 2025. Among hospitalist clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 179 payments — averaging $12.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$370
- AstraZeneca$234
- Boehringer Ingelheim$196
- Johnson & Johnson$156
- Daiichi Sankyo Inc.$156
- Amarin Pharma, Inc.$149
- plus $909 from 16 others
What the payments were for
- Food & beverage$2,164100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 51 | $370 |
| AstraZeneca | 17 | $234 |
| Boehringer Ingelheim | 14 | $196 |
| Johnson & Johnson | 11 | $156 |
| Daiichi Sankyo Inc. | 11 | $156 |
| Amarin Pharma, Inc. | 11 | $149 |
| Sanofi-aventis U.S. LLC | 10 | $137 |
| Lilly USA, LLC | 10 | $132 |
| Pfizer | 9 | $130 |
| Merck | 8 | $113 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $100 |
| Novartis | 3 | $40 |
| Sanofi Pasteur Inc. | 3 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| AbbVie | 2 | $36 |
| Philips North America LLC | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $26 |
| E.r. Squibb & Sons, L.L.C. | 2 | $24 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $17 |
| Mylan Specialty L.p. | 1 | $16 |
| GSK | 1 | $15 |
| Hologic Sales And Service, LLC | 1 | $13 |
How this compares
$2,170 in reported general payments places this provider in the 95th percentile of 567 hospitalist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefpodoxime Proxetil | 15 | $404 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $218 |
| Doxycycline Hyclate | 22 | $172 |
| Pantoprazole Sodium | 16 | $97 |
| Carvedilol | 18 | $63 |
| Tamsulosin Hcl | 12 | $59 |
| Prednisone | 18 | $55 |
| Metoprolol Tartrate | 17 | $55 |
| Furosemide | 16 | $53 |
| Amlodipine Besylate | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Pomona
- Mohammed UsmanToms River$33K
- Justin BaptistAtlantic City$23K
- Jhonsua Jimenez AriasMorristown$15K
- Ahmed HassaninMorristown$15K
- Mohamed BakrAtlantic City$8K
- Jason NehmadNeptune$7K
- Rebecca ZweiflerMorristown$6K
- Scott KaufmanMount Holly$6K
- Kunal ParmarPompton Plains$6K
- Sameh GirgisNeptune$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.